Загрузка...
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Since the clear demonstration of lysophosphatidic acid (LPA)’s pathological roles in cancer in the mid-1990s, more than 1000 papers relating LPA to various types of cancer were published. Through these studies, LPA was established as a target for cancer. Although LPA-related inhibitors entered clini...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826372/ https://ncbi.nlm.nih.gov/pubmed/31658655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101523 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|